A Pharmacokinetic Study of DW6012 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
Clinical trial NCT05403281 · COMPLETED
Trial details
- NCT number
- NCT05403281
- Sponsor
- Dong Wha Pharmaceutical Co. Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2021-12-03
- Enrollment
- 41
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.